Has your activity changed since the start of the pandemic?
The MHRA (Medicines and Healthcare products Regulatory Agency) and European Commission have granted marketing authorisation for an under-the-skin injection of Tysabri. Tysabri is a disease-modifying therapy for highly active relapsing-remitting MS.
UK experts are set to run a multi-arm, multi-stage trial which will test a range of drugs already approved for other illnesses for the treatment of multiple sclerosis (MS). The ‘Octopus trial’ will allow three drugs to be tested at the same time.
All-Ireland MS Research Network (AIMS-RN) provides hope to those affected by multiple sclerosis
You are invited to participate in a study which will explore the perception of CBD oil.
Issue 7 is out now!
Lauren McCauley, person living with MS, patient advisor and a participant
Conducting research remotely by Fionnuala Rogers, Research Assistant at NUI Galway with the COB-MS feasibility trial.
A case study of anxiety in MS by Dr Rebecca Maguire - Associate Professor, Department of Psychology, Maynooth University
Researchers at Trinity College Dublin and Beaumont Hospital are carrying out a study exploring cognitive changes (thinking and memory) in Multiple Sclerosis.